Kunkel Lori Anne - Insider Non-Derivative Transactions at Enliven Therapeutics, Inc. (ELVN) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Dec 17, 2025, Kunkel Lori Anne's relationship to Enliven Therapeutics, Inc. (ELVN) is Director, and currently has 30,712 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ELVN insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Kunkel Lori Anne - Insider Non-Derivative Transactions of ELVN Common Stock

Kunkel Lori Anne - Insider Non-Derivative Transactions at ELVN

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 18, 2025	M -- (Common Stock)	15958	1.12	30712